IAN MORGAN: Open Payments
NPI 1326721812 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $849 · 2025 $1,260
Food & beverage: $1,260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $375 |
| Enterra Medical, Inc. | 2 | $172 |
| Madrigal Pharmaceuticals | 1 | $150 |
| GENZYME CORPORATION | 2 | $136 |
| Gilead Sciences, Inc. | 1 | $111 |
| Aimmune Therapeutics, Inc. | 1 | $110 |
| Boston Scientific Corporation | 3 | $105 |
| Merit Medical Systems Inc | 1 | $101 |
Products named: REZDIFFRA, DUPIXENT, SKYRIZI, LINZESS, Livdelzi, ZENPEP, General - Therapies, ESOPHYX.
Industry payments across AZ — which companies pay providers there.
